These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

187 related items for PubMed ID: 7572679

  • 21. Screening experience and baseline characteristics in the West of Scotland Coronary Prevention Study. The WOSCOPS Study Group. West of Scotland Coronary Prevention Study.
    Am J Cardiol; 1995 Sep 01; 76(7):485-91. PubMed ID: 7653449
    [Abstract] [Full Text] [Related]

  • 22. A coronary primary intervention study of Japanese men: study design, implementation and baseline data. The Kyushu Lipid Intervention Study Group.
    J Atheroscler Thromb; 1996 Sep 01; 3(2):95-104. PubMed ID: 9226461
    [Abstract] [Full Text] [Related]

  • 23. Reduction of stroke incidence after myocardial infarction with pravastatin: the Cholesterol and Recurrent Events (CARE) study. The Care Investigators.
    Plehn JF, Davis BR, Sacks FM, Rouleau JL, Pfeffer MA, Bernstein V, Cuddy TE, Moyé LA, Piller LB, Rutherford J, Simpson LM, Braunwald E.
    Circulation; 1999 Jan 19; 99(2):216-23. PubMed ID: 9892586
    [Abstract] [Full Text] [Related]

  • 24. [Victory in primary prevention--or? Can we afford to translate results from the West-of-Scotland Study into general practice?].
    Klose G.
    Fortschr Med; 1996 Jun 20; 114(17):231-2. PubMed ID: 8767302
    [No Abstract] [Full Text] [Related]

  • 25. Effect of pravastatin on cardiovascular events and mortality in 1516 women with coronary heart disease: results from the Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) study.
    Hague W, Forder P, Simes J, Hunt D, Tonkin A, LIPID Investigators.
    Am Heart J; 2003 Apr 20; 145(4):643-51. PubMed ID: 12679760
    [Abstract] [Full Text] [Related]

  • 26. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels.
    Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group.
    N Engl J Med; 1998 Nov 05; 339(19):1349-57. PubMed ID: 9841303
    [Abstract] [Full Text] [Related]

  • 27. Pravastatin. A pharmacoeconomic review of its use in primary and secondary prevention of coronary heart disease.
    Coukell AJ, Wilde MI.
    Pharmacoeconomics; 1998 Aug 05; 14(2):217-36. PubMed ID: 10186462
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Beneficial effects of pravastatin (+/-colestyramine/niacin) initiated immediately after a coronary event (the randomized Lipid-Coronary Artery Disease [L-CAD] Study).
    Arntz HR, Agrawal R, Wunderlich W, Schnitzer L, Stern R, Fischer F, Schultheiss HP.
    Am J Cardiol; 2000 Dec 15; 86(12):1293-8. PubMed ID: 11113401
    [Abstract] [Full Text] [Related]

  • 31. Design, rational, and baseline characteristics of the Prospective Pravastatin Pooling (PPP) project--a combined analysis of three large-scale randomized trials: Long-term Intervention with Pravastatin in Ischemic Disease (LIPID), Cholesterol and Recurrent Events (CARE), and West of Scotland Coronary Prevention Study (WOSCOPS).
    Am J Cardiol; 1995 Nov 01; 76(12):899-905. PubMed ID: 7484829
    [Abstract] [Full Text] [Related]

  • 32. Management of the Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) study after the Scandinavian Simvastatin Survival Study (4S).
    Tonkin AM.
    Am J Cardiol; 1995 Sep 28; 76(9):107C-112C. PubMed ID: 7572678
    [Abstract] [Full Text] [Related]

  • 33. Statins and coronary heart disease.
    Fey R, Pearson N.
    Lancet; 1996 May 18; 347(9012):1389-90. PubMed ID: 8637349
    [No Abstract] [Full Text] [Related]

  • 34. Lipid lowering in post-MI patients with normal cholesterol.
    Lawless C, Force R.
    J Fam Pract; 1997 Jan 18; 44(1):30. PubMed ID: 9010366
    [No Abstract] [Full Text] [Related]

  • 35. Long-term follow-up of the West of Scotland Coronary Prevention Study.
    McEvoy JW, Margey R, Blake GJ.
    N Engl J Med; 2008 Jan 10; 358(2):193; author reply 194-5. PubMed ID: 18184967
    [No Abstract] [Full Text] [Related]

  • 36. Prospective meta-analysis of cholesterol-lowering studies: the Prospective Pravastatin Pooling (PPP) Project and the Cholesterol Treatment Trialists (CTT) Collaboration.
    Simes RJ.
    Am J Cardiol; 1995 Sep 28; 76(9):122C-126C. PubMed ID: 7572681
    [Abstract] [Full Text] [Related]

  • 37. Statins and coronary artery disease--it's the clinical endpoints that count.
    Jackson G.
    Br J Clin Pract; 1997 Sep 28; 51(1):2-3. PubMed ID: 9158261
    [No Abstract] [Full Text] [Related]

  • 38. Effect of pravastatin on cardiovascular events in older patients with myocardial infarction and cholesterol levels in the average range. Results of the Cholesterol and Recurrent Events (CARE) trial.
    Lewis SJ, Moye LA, Sacks FM, Johnstone DE, Timmis G, Mitchell J, Limacher M, Kell S, Glasser SP, Grant J, Davis BR, Pfeffer MA, Braunwald E.
    Ann Intern Med; 1998 Nov 01; 129(9):681-9. PubMed ID: 9841599
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. West of Scotland Coronary Prevention Study: identification of high-risk groups and comparison with other cardiovascular intervention trials.
    Lancet; 1996 Nov 16; 348(9038):1339-42. PubMed ID: 8918276
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.